CSPC Pharmaceutical Group... (CHJTF)
OTC: CHJTF
· Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 05, 2025, 12:35 PM
CSPC Pharmaceutical Revenue
CSPC Pharmaceutical reported an annual revenue of $30.87B, reflecting a -10.78% growth. For the quarter ending December 31, 2024, CSPC Pharmaceutical generated $14.59B in revenue.
Revenue (ttm)
30.87B
Revenue Growth
-10.78%
Price / Sales Ratio
1.74
Revenue / Employee
1.44M
Employees
21,400
Market Cap
14.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 30.87B | -10.78% |
| Dec 31, 2023 | 34.6B | +9.53% |
| Dec 31, 2022 | 31.59B | -5.94% |
| Dec 31, 2021 | 33.59B | +19.83% |
| Dec 31, 2020 | 28.03B | +11.83% |
| Dec 31, 2019 | 25.06B | +35.71% |
| Dec 31, 2018 | 18.47B | +42.94% |
| Dec 31, 2017 | 12.92B | +16.66% |
| Dec 31, 2016 | 11.08B | +16.08% |
| Dec 31, 2015 | 9.54B | +8.91% |
| Dec 31, 2014 | 8.76B | +12.68% |
| Dec 31, 2013 | 7.77B | +132.85% |
| Dec 31, 2012 | 3.34B | -44.10% |
| Dec 31, 2011 | 5.97B | -9.86% |
| Dec 31, 2010 | 6.63B | +7.02% |
| Dec 31, 2009 | 6.19B | +2.95% |
| Dec 31, 2008 | 6.01B | +28.75% |
| Dec 31, 2007 | 4.67B | +31.64% |
| Dec 31, 2006 | 3.55B | +6.79% |
| Dec 31, 2005 | 3.32B | +27.26% |
| Dec 31, 2004 | 2.61B | -1.20% |
| Dec 31, 2003 | 2.64B | n/a |